ALID Stock Analysis
AL
Uncovered
Allied Corp is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Allied Corp. engages in the research, creation, and production of cannabinoid health solutions. The company is headquartered in Kelowna, British Columbia. The company went IPO on 2018-12-04. The firm is focused on the development of medicinal cannabis and psilocybin products for patients with conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI)1.